We are live on
!
Find out more
TCM
Tao Capital Management Portfolio holdings
AUM
$119M
1-Year Est. Return
87.46%
This Fund
S&P 500
This Quarter
Est. Return
+14.48%
1 Year Est. Return
+87.46%
3 Year Est. Return
+356.21%
5 Year Est. Return
+280.73%
10 Year Est. Return
–
AUM
$436M
AUM Growth
+$89.5M
(+26%)
Cap. Flow
+$49.5M
Cap. Flow
% of AUM
11.35%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
1
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IS
ironSource Ltd.
IS
|
+$39.8M |
| 2 |
ZY
Zymergen Inc. Common Stock
ZY
|
+$9.77M |
| 3 |
Uber
UBER
|
+$1.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
908 Devices
MASS
|
+$976K |
| 2 |
Denali Therapeutics
DNLI
|
+$348K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 55.96% |
| 2 | Healthcare | 33.83% |
| 3 | Consumer Discretionary | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ouster
OUST
$2.29B
| $141M | 32.25% |
1,125,315
| – | – |
|
2
Twist Bioscience
TWST
$5.63B
| $110M | 25.34% |
828,815
| – | – |
|
|
3
Uber
UBER
$136B
| $64.4M | 14.78% |
1,284,851
+22,975
| +2% | +$1.2M |
|
4
Tesla
TSLA
$1.22T
| $39.1M | 8.97% |
172,500
| – | – |
|
|
IS
5
DELISTED
ironSource Ltd.
IS
| $38.9M | 8.93% |
+3,704,460
| New | +$39.8M |
|
|
6
908 Devices
MASS
$294M
| $22M | 5.06% |
568,981
-21,538
| -4% | -$976K |
|
|
ZY
7
DELISTED
Zymergen Inc. Common Stock
ZY
| $9.91M | 2.27% |
+247,690
| New | +$9.77M |
|
8
Hyatt Hotels
H
$18B
| $5.43M | 1.25% |
70,000
| – | – |
|
9
Madrigal Pharmaceuticals
MDGL
$13B
| $5.01M | 1.15% |
51,396
| – | – |
|
|
10
Denali Therapeutics
DNLI
$3.79B
| – | – |
-6,086
| Closed | -$348K |
|
Similar funds
SF
MWML
MWM
VA
HPM
SKK
WKSWA
CA
Tao Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Tao Capital Management held 10 positions worth $436M, up 26% from $346M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tao Capital Management deployed $49.5M of net new capital in Q2 2021, opening 2 new positions and adding to 1 existing holding. Its largest new stake was ironSource Ltd.: 3,704,460 shares worth $38.9M.
By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 47% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was 908 Devices, an estimated $976K trimmed.
- Tao Capital Management's largest Q2 2021 buy was ironSource Ltd.: 3,704,460 shares worth $38.9M.
- Tao Capital Management added most to Uber in Q2 2021, an estimated $1.2M increase.
- Tao Capital Management's biggest Q2 2021 reduction was 908 Devices, cutting an estimated $976K.
- Tao Capital Management fully exited Denali Therapeutics in Q2 2021, selling an estimated $348K.
- Tao Capital Management's ten largest holdings make up 100% of its $436M portfolio in Q2 2021.
- Tao Capital Management opened 2 new positions and closed 1 in Q2 2021.
- Tao Capital Management's portfolio value rose 26% quarter-over-quarter to $436M.
Based on Tao Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.